Irit Arbel, Director at Brainstorm Cell Therapeutics, holds 155.83K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 0.00 shares in Pluri (Ticker: PLUR). Most recently, Irit Arbel Sold ― shares of Brainstorm Cell Therapeutics on Aug 30, 2019 for an estimated value of 48.80K.